Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FDQXN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $16,249.95, was awarded to DMS Pharmaceutical Group Inc. for the supply of Stelara 90 mg/mL syringes by the Defense Logistics Agency (DLA) on July 23, 2025, with an ultimate completion date of August 13, 2025. The award utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the prime contractor. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which carries a potential value of $499,999,999 through November 2026 and enables the agency to procure pharmaceutical products supporting Department of Defense healthcare facilities nationwide.
Stelara is a biologic medication commonly used for treating autoimmune conditions, and this delivery order reflects DMS Pharmaceutical Group's ongoing role as a critical supplier within the federal pharmaceutical supply chain. The company's contract history demonstrates consistent success in delivering specialized pharmaceutical products, including biologics, prescription medications, and medical consumables to military health facilities. The firm fixed-price structure provides cost certainty for this pharmaceutical delivery, with performance scheduled for completion within approximately three weeks of the award date.
Quick answers
Who was awarded contract SPE2DB25FDQXN?
SPE2DB25FDQXN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FDQXN worth?
The government has obligated $16,250 on SPE2DB25FDQXN.
Is contract SPE2DB25FDQXN an order under another contract?
Yes. SPE2DB25FDQXN is a delivery order under SPE2DB24D9238, an indefinite delivery contract.
Was contract SPE2DB25FDQXN competed?
The extent of competition for SPE2DB25FDQXN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award